Back to Search Start Over

Remote Observational Research for Multiple Sclerosis: A Natural Experiment.

Authors :
Bove R
Poole S
Cuneo R
Gupta S
Sabatino J Jr
Harms M
Cooper T
Rowles W
Miller N
Gomez R
Lincoln R
McPolin K
Powers K
Santaniello A
Renschen A
Bevan CJ
Gelfand JM
Goodin DS
Guo CY
Romeo AR
Hauser SL
Campbell Cree BA
Source :
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2022 Dec 30; Vol. 10 (2). Date of Electronic Publication: 2022 Dec 30 (Print Publication: 2023).
Publication Year :
2022

Abstract

Background and Objectives: Prospective, deeply phenotyped research cohorts monitoring individuals with chronic neurologic conditions, such as multiple sclerosis (MS), depend on continued participant engagement. The COVID-19 pandemic restricted in-clinic research activities, threatening this longitudinal engagement, but also forced adoption of televideo-enabled care. This offered a natural experiment in which to analyze key dimensions of remote research: (1) comparison of remote vs in-clinic visit costs from multiple perspectives and (2) comparison of the remote with in-clinic measures in cross-sectional and longitudinal disability evaluations.<br />Methods: Between March 2020 and December 2021, 207 MS cohort participants underwent hybrid in-clinic and virtual research visits; 96 contributed 100 "matched visits," that is, in-clinic (Neurostatus-Expanded Disability Status Scale [NS-EDSS]) and remote (televideo-enabled EDSS [tele-EDSS]; electronic patient-reported EDSS [ePR-EDSS]) evaluations. Clinical, demographic, and socioeconomic characteristics of participants were collected.<br />Results: The costs of remote visits were lower than in-clinic visits for research investigators (facilities, personnel, parking, participant compensation) but also for participants (travel, caregiver time) and carbon footprint ( p < 0.05 for each). Median cohort EDSS was similar between the 3 modalities (NS-EDSS: 2, tele-EDSS: 1.5, ePR-EDSS: 2, range 0.6.5); the remote evaluations were each noninferior to the NS-EDSS within ±0.5 EDSS point (TOST for noninferiority, p < 0.01 for each). Furthermore, year to year, the % of participants with worsening/stable/improved EDSS scores was similar, whether each annual evaluation used NS-EDSS or whether it switched from NS-EDSS to tele-EDSS.<br />Discussion: Altogether, the current findings suggest that remote evaluations can reduce the costs of research participation for patients, while providing a reasonable evaluation of disability trajectory longitudinally. This could inform the design of remote research that is more inclusive of diverse participants.<br /> (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.)

Details

Language :
English
ISSN :
2332-7812
Volume :
10
Issue :
2
Database :
MEDLINE
Journal :
Neurology(R) neuroimmunology & neuroinflammation
Publication Type :
Academic Journal
Accession number :
36585249
Full Text :
https://doi.org/10.1212/NXI.0000000000200070